Melatonin, selective and non-selective MT1/MT2 receptors agonists: Differential effects on the 24-h vigilance states

Neuroscience Letters

Volumn 561, Issue , 2014, Pages 156-161

  Ochoa Sanchez, Rafael ^a   Comai, Stefano ^a   Spadoni, Gilberto ^b   Bedini, Annalida ^b   Tarzia, Giorgio ^b   Gobbi, Gabriella ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b UNIVERSITY OF URBINO   (Italy)

Author keywords

Melatonin; MT1 receptor; MT2 receptor; Sleep wake cycle; UCM793; UCM924

Indexed keywords

MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; PARTIAL AGONIST;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DELTA RHYTHM; ELECTROENCEPHALOGRAM; ELECTROMYOGRAM; LIGHT DARK CYCLE; NONHUMAN; NONREM SLEEP; PRIORITY JOURNAL; RAT; REM SLEEP; SLEEP SPINDLE; SLEEP TIME; SLEEP WAKING CYCLE; WAKEFULNESS;

MELATONIN; MT(1) RECEPTOR; MT(2) RECEPTOR; SLEEP-WAKE CYCLE; UCM793; UCM924;

ACETAMIDES; ANILINE COMPOUNDS; ANIMALS; DRUG PARTIAL AGONISM; ELECTROENCEPHALOGRAPHY; MALE; MELATONIN; RATS, SPRAGUE-DAWLEY; RECEPTOR, MELATONIN, MT1; RECEPTOR, MELATONIN, MT2; SLEEP STAGES; SLEEP, REM; WAKEFULNESS;

EID: 84892638587     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.12.069     Document Type: Article

References (21)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington, DC. IV Edition.
2. Comai S., Ochoa-Sanchez R., Gobbi G. Sleep-wake characterization of double MT1/MT2 receptor knockout mice and comparison with MT1 and MT2 receptor knockout mice. Behavioural Brain Research 2013, 243:231-238.
3. Fisher S.P., Davidson K., Kulla A., Sugden D. Acute sleep-promoting action of the melatonin agonist, ramelteon, in the rat. Journal of Pineal Research 2008, 45:125-132.
4. Fisher S.P., Sugden D. Sleep-promoting action of IIK7, a selective MT2 melatonin receptor agonist in the rat. Neuroscience Letters 2009, 457:93-96.
5. Gershell L. Insomnia market. Nature Reviews Drug Discovery 2006, 5:15-16.
6. Holmes S.W., Sugden D. Effects of melatonin on sleep and neurochemistry in the rat. British Journal of Pharmacology 1982, 76:95-101.
7. James S.P., Mendelson W.B., Sack D.A., Rosenthal N.E., Wehr T.A. The effect of melatonin on normal sleep. Neuropsychopharmacology 1987, 1:41-44.
8. Jan J.E., Reiter R.J., Wong P.K.H., Bax M.C.O., Ribary U., Wasdell M.B. Melatonin has membrane receptor-independent hypnotic action on neurons: an hypothesis. Journal of Pineal Research 2010, 50:233-240.
9. Lankford D.A. Tasimelteon for insomnia. Expert Opinion on Investigational Drugs 2011, 20:987-993.
10. LeBlanc M., Merette C., Savard J., Ivers H., Baillargeon L., Morin C.M. Incidence and risk factors of insomnia in a population-based sample. Sleep 2009, 32:1027-1037.
11. Mailliet F., Galloux P., Poisson D. Comparative effects of melatonin, zolpidem and diazepam on sleep, body temperature, blood pressure and heart rate measured by radiotelemetry in Wistar rats. Psychopharmacology 2001, 156:417-426.
12. Mirmiran M., Pevet P. Effects of melatonin and 5-methoxytryptamine on sleep-wake patterns in the male-rat. Journal of Pineal Research 1986, 3:135-141.
13. Ochoa-Sanchez R., Comai S., Lacoste B., Bambico F.R., Dominguez-Lopez S., Spadoni G., Rivara S., Bedini A., Angeloni D., Fraschini F., Mor M., Tarzia G., Descarries L., Gobbi G. Promotion of non-rapid eye movement sleep and activation of reticular thalamic neurons by a novel MT2 melatonin receptor ligand. Journal of Neuroscience 2011, 31:18439-18452.
14. Ochoa-Sanchez R., Rainer Q., Comai S., Spadoni G., Bedini A., Rivara S., Fraschini F., Mor M., Tarzia G., Gobbi G. Anxiolytic effects of the melatonin MT(2) receptor partial agonist UCM765: comparison with melatonin and diazepam. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2012, 39:318-325.
15. Rajaratnam S.M., Middleton B., Stone B.M., Arendt J., Dijk D.J. Melatonin advances the circadian timing of EEG sleep and directly facilitates sleep without altering its duration in extended sleep opportunities in humans. Journal of Physiology 2004, 561:339-351.
16. Reiter R.J., Tan D.X., Fuentes-Broto L. Melatonin: a multitasking molecule. Progress in Brain Research 2010, 181:127-151.
17. Rivara S., Lodola A., Mor M., Bedini A., Spadoni G., Lucini V., Pannacci M., Fraschini F., Scaglione F., Ochoa-Sanchez R., Gobbi G., Tarzia G. N-(Substituted-anilinoethyl)amides: design, synthesis, and pharmacological characterization of a new class of melatonin receptor ligands. Journal of Medicinal Chemistry 2007, 50:6618-6626.
18. Rivara S., Vacondio F., Fioni A., Silva C., Carmi C., Mor M., Lucini V., Pannacci M., Caronno A., Scaglione F., Gobbi G., Spadoni G., Bedini A., Orlando P., Lucarini S., Tarzia G. N-(Anilinoethyl)amides. Design metabolically stable, selective and synthesis of melatonin receptor ligands. ChemMedChem 2009, 4:1746-1755.
19. Tobler I., Jaggi K., Borbely A.A. Effects of melatonin and the melatonin receptor agonist S-20098 on the vigilance states, eeg spectra, and cortical temperature in the rat. Journal of Pineal Research 1994, 16:26-32.
20. Tzischinsky O., Lavie P. Melatonin possesses time-dependent hypnotic effects. Sleep 1994, 17:638-645.
21. Zhdanova I.V. Melatonin as a hypnotic: pro. Sleep Medicine Reviews 2005, 9:51-65.